Analyst Insights: Monster Beverage, Conceptus, GNC, Bridgepoint, Warner Chilcott April 30th
Conceptus, Inc. (NASDAQ:CPTS): After Conceptus (NASDAQ:CPTS) reached a settlement with Hologic (NASDAQ:HOLX) over Essure, Barrington thinks that Conceptus will, as a result of the settlement, be able to regain all of the share it lost to Hologic. The firm reiterates a $20 target and Outperform rating on Conceptus.
GNC Holdings Inc (NYSE:GNC): GNC Holdings weakness a buying opportunity, says JPMorgan
Bridgepoint Education, Inc. (NYSE:BPI): Barrington predicts that Bridgepoint Education’s enrollment declined by a lower than expected amount in Q1, and the firm thinks that the stock’s valuation is very compelling. The firm maintains an Outperform rating on the stock.
Warner Chilcott plc (NASDAQ:WCRX): Needham remains skeptical of a bid by Bayer for Warner Chilcott anywhere near $32 per share given lack of compelling strategic rationale.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.